Corient Private Wealth Portfolio holdings
Corient Private Wealth is the U.S. wealth management business that grew out of Canadian asset manager CI Financial's push into American wealth advisers. It was called CI Private Wealth until 2023, when it took the name Corient, a play on the words "client" and "oriented." Its advisers typically manage client portfolios by hiring and replacing outside investment managers and choosing individual securities, guided by an investment committee. Clients include individuals, among them high-net-worth individuals, as well as trusts, estates and charitable organizations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$313M |
| 2 |
RTX Corp
RTX
|
+$247M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$246M |
| 4 |
Quanta Services
PWR
|
+$126M |
| 5 |
Marvell Technology
MRVL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$449M |
| 2 |
NVIDIA
NVDA
|
+$392M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$375M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$331M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.68% |
| 2 | Technology | 19.67% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 7.58% |
| 5 | Healthcare | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1476
Vital Farms
VITL
$372M
| $1.75M | ﹤0.01% |
+150,626
| New | +$1.68M |
2026 Q2
0 quarters
|
|
1477
PennyMac Mortgage Investment
PMT
$651M
| $1.75M | ﹤0.01% |
+154,905
| New | +$1.71M |
2026 Q2
0 quarters
|
|
1478
Vicor
VICR
$8.82B
| $1.75M | ﹤0.01% |
4,596
+669
| +17% | +$183K |
2025 Q3
3 quarters
|
|
1479
Nuveen ESG Large-Cap Growth ETF
NULG
$2.89B
| $1.74M | ﹤0.01% |
14,887
-16,029
| -52% | -$1.72M |
2022 Q4
14 quarters
|
|
1480
ORIX
IX
$39.6B
| $1.74M | ﹤0.01% |
45,724
+3,113
| +7% | +$111K |
2023 Q1
13 quarters
|
|
1481
Xenon Pharmaceuticals
XENE
$3.62B
| $1.73M | ﹤0.01% |
28,732
+430
| +2% | +$23.9K |
2026 Q1
1 quarter
|
|
1482
PTC
PTC
$21.2B
| $1.73M | ﹤0.01% |
15,247
-6,159
| -29% | -$832K |
2023 Q2
12 quarters
|
|
1483
Lincoln National
LNC
$7.85B
| $1.73M | ﹤0.01% |
48,941
-5,398
| -10% | -$194K |
2022 Q4
14 quarters
|
|
1484
State Street SPDR S&P Metals & Mining ETF
XME
$3.69B
| $1.73M | ﹤0.01% |
16,172
-8,486
| -34% | -$996K |
2024 Q2
8 quarters
|
|
1485
Franklin FTSE Switzerland ETF
FLSW
$93.2M
| $1.72M | ﹤0.01% |
39,722
-1,726
| -4% | -$73.7K |
2023 Q1
13 quarters
|
|
1486
Nuveen ESG Large-Cap Value ETF
NULV
$2.6B
| $1.72M | ﹤0.01% |
34,386
-74,727
| -68% | -$3.69M |
2022 Q4
14 quarters
|
|
1487
Encompass Health
EHC
$13.4B
| $1.72M | ﹤0.01% |
16,988
+1,358
| +9% | +$141K |
2023 Q1
13 quarters
|
|
1488
Wipro
WIT
$21.4B
| $1.71M | ﹤0.01% |
762,207
+116,910
| +18% | +$249K |
2022 Q4
14 quarters
|
|
1489
Imperial Oil
IMO
$66.8B
| $1.71M | ﹤0.01% |
15,282
-233
| -2% | -$29.2K |
2022 Q4
14 quarters
|
|
1490
Centuri Holdings
CTRI
$2.17B
| $1.71M | ﹤0.01% |
56,606
+1,471
| +3% | +$47.5K |
2026 Q1
1 quarter
|
|
1491
First Trust United Kingdom AlphaDEX Fund
FKU
$35.5M
| $1.71M | ﹤0.01% |
32,528
+84
| +0.3% | +$4.47K |
2023 Q1
13 quarters
|
|
1492
UGI
UGI
$8.29B
| $1.7M | ﹤0.01% |
49,142
+11,158
| +29% | +$394K |
2023 Q3
11 quarters
|
|
1493
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $1.7M | ﹤0.01% |
31,907
-11,565
| -27% | -$635K |
2022 Q4
14 quarters
|
|
1494
Douglas Dynamics
PLOW
$911M
| $1.7M | ﹤0.01% |
31,447
+16,813
| +115% | +$775K |
2026 Q1
1 quarter
|
|
1495
NEOS Bitcoin High Income ETF
BTCI
$1.31B
| $1.69M | ﹤0.01% |
63,086
-4,573
| -7% | -$153K |
2025 Q2
4 quarters
|
|
1496
Teva Pharmaceutical Industries Limited
TEVA
$49.1B
| $1.69M | ﹤0.01% |
49,994
-1,670
| -3% | -$55.6K |
2022 Q4
14 quarters
|
|
1497
T. Rowe Price Value ETF
TVAL
$1.12B
| $1.69M | ﹤0.01% |
40,525
| – | – |
2025 Q1
5 quarters
|
|
1498
The Ensign Group
ENSG
$10.6B
| $1.69M | ﹤0.01% |
10,519
-12,628
| -55% | -$2.23M |
2022 Q4
14 quarters
|
|
1499
Morningstar
MORN
$8.39B
| $1.68M | ﹤0.01% |
10,796
-8,334
| -44% | -$1.45M |
2022 Q4
14 quarters
|
|
1500
John Wiley & Sons Class A
WLY
$2.59B
| $1.68M | ﹤0.01% |
34,685
+16,889
| +95% | +$710K |
2026 Q1
1 quarter
|
|
Similar funds
Corient Private Wealth's Q2 2026 Portfolio in Review
As of Q2 2026, Corient Private Wealth held 3,273 positions worth $72.2B, up 3.4% from $69.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Corient Private Wealth withdrew a net $6.91B in Q2 2026, closing 231 positions and reducing 1,294 holdings. Its most notable exit was Masimo, an estimated $57.2M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 37% a quarter earlier, followed by Technology and Financials.
Against the trend, Corient Private Wealth opened a new position in Powerlaw Corp worth $56.7M.
- Corient Private Wealth's largest Q2 2026 buy was Powerlaw Corp: 3,862,217 shares worth $56.7M.
- Corient Private Wealth added most to Invesco QQQ Trust in Q2 2026, an estimated $313M increase.
- Corient Private Wealth's biggest Q2 2026 reduction was Schwab International Equity ETF, cutting an estimated $449M.
- Corient Private Wealth fully exited Masimo in Q2 2026, selling an estimated $57.2M.
- Corient Private Wealth's ten largest holdings make up 27% of its $72.2B portfolio in Q2 2026.
- Corient Private Wealth opened 439 new positions and closed 231 in Q2 2026.
- Corient Private Wealth's portfolio value rose 3.4% quarter-over-quarter to $72.2B.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.